阿替利珠联合贝伐珠治疗晚期肝癌的安全性及有效性的荟萃分析Meta-Analysis of Safety and Efficacy of Atezolizumab plus Bevacizumab in Advanced Hepatocelluar Carcinoma
田维松, 陈治梁, 余天雾
临床个性化医学Vol.4 No.2, 全文下载: PDF XML DOI:10.12677/jcpm.2025.42151, March 26 2025
贝伐单抗在肝癌治疗中的应用现状及进展Bevacizumab: Current Approach in the Treatment of Hepatocellular Carcinoma
钱坤, 钱骏
医学诊断Vol.1 No.1, 全文下载: PDF HTML XML DOI:10.12677/md.2011.11001, September 28 2011
联合临床指标和多期动态增强CT影像学特征在术前预测肝细胞癌微血管侵犯中的价值探讨Exploring the Value of Combined Clinical Indicators and Multiphase Dynamic Contrast-Enhanced CT Imaging Characteristics for Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma
胡敬梅, 李 欢, 王龙胜
临床医学进展Vol.15 No.1, 全文下载: PDF XML DOI:10.12677/acm.2025.151289, January 30 2025
阿替利珠单抗联合贝伐珠单抗治疗肝细胞癌的现况Current Status of Atezolizumab Combined with Bevacizumab in the Treatment of HepatocellularCarcinoma
田维松, 余天雾
临床医学进展Vol.14 No.12, 全文下载: PDF XML DOI:10.12677/acm.2024.14123080, December 11 2024
肝动脉灌注化疗在中晚期肝癌联合治疗中的作用The Role of Hepatic Arterial Infusion Chemotherapy in the Combination Therapy of Advanced Hepatocellular Carcinoma
苏 涛, 孙 航, 吴传新 国家自然科学基金支持
临床医学进展Vol.12 No.3, 全文下载: PDF HTML XML DOI:10.12677/ACM.2022.123271, March 17 2022
肝动脉化疗栓塞术联合甲磺酸阿帕替尼片治疗晚期肝癌的疗效及安全性评价Efficacy and Safety of Transarterial Chemoembolization Combined with Apatinib Mesylate in Patients with Advanced Hepatocellular Carcinoma
秦立东, 邓庆潇, 王 楠 科研立项经费支持
临床医学进展Vol.9 No.11, 全文下载: PDF HTML XML DOI:10.12677/ACM.2019.911207, November 27 2019